Equities researchers at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Onto ...
President Trump pumped the brakes last week on a pledge to shut down an import tax exemption for cheap consumer goods from ...
Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...
Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...
In a report released today, Deepak Mathivanan from Cantor Fitzgerald maintained a Hold rating on Expedia (EXPE – Research Report), with a price ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
LKQ Corporation (LKQ) filed suit against Robert Rutledge, its former plant manager, in the U.S. District Court for the Northern District ...
Cantor Fitzgerald analyst Colin Canfield initiated coverage of Amentum (AMTM) with a Neutral rating and $25 price target Maximize Your ...
CNBC recently spoke to companies worldwide on how DeepSeek’s new AI models will likely impact their operations and financials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback